Clinical Efficacy and Safety of Imatinib in the Management of Ph+ Chronic Myeloid or Acute Lymphoblastic Leukemia in Chinese Patients

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s38846
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited